Furthermore, relapsing-remitting multiple sclerosis (
RRMS) is the most common form of MS (1).
Their effectiveness is comparable in the treatment of the
RRMS [14].
Global Markets Direct's, 'Relapsing Remitting Multiple Sclerosis (
RRMS) - Pipeline Review, H1 2014', provides an overview of the Relapsing Remitting Multiple Sclerosis (
RRMS)'s therapeutic pipeline.
The
RRMS patients had shorter disease duration and lower EDSS scores than patients with SPMS or PPMS.
Those who develop secondary-progressive MS (SPMS) after having
RRMS often have similar feelings.
Among the other presentations were a preliminary analysis of a study assessing disease course and quality-of life outcomes of patients switching to Teva's Copaxone (glatiramer acetate injection) from other approved injectable and infused disease-modifying therapies for
RRMS, and data showing the effects of Copaxone treatment on progression of disability, cognition and fatigue and the impact of these factors on compliance and adherence.
The model included a 3-level MS type factor (
RRMS, SPMS, and control), 2-level noise exposure factor (yes and no) and 2-level use of ototoxic medication factor (yes and no).
Now, 7 DMTs are available for the treatment of
RRMS in the United States.
Natalizumab is a disease-modifying therapy (DMT) that was approved for use over 10 years ago, offering patients a valuable therapeutic option for treating
RRMS.
Around 85% of people with multiple sclerosis (MS) are diagnosed with
RRMS. It has been highlighted that providing access to disease-modifying therapies (DMTs) for MS represents a considerable challenge for healthcare systems.
Although there exists an abundance of literature examining many different aspects of MS and MS symptoms, there is a paucity of literature exploring the whole life experience of living with MS, and more specifically,
RRMS. The aim of this study was to gain insights and understanding into the lived experience of
RRMS, so that nurses may have a deeper understanding of the patient experience and be able to plan and adjust their nursing care accordingly.
Multiple sclerosis (MS; MIM 126200) is a common, partially heritable central nervous system (CNS) autoimmune disorder being considered as one of the most common causes of neurological disability in young adults.[1],[2] Relapsing-remitting MS (
RRMS) is the most common form of MS which has a biphasic disease course characterized by alternating episodes of acute neurological deficits, followed by a complete or partial recovery.